CHEBI:63959 - celastrol

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name celastrol
Definition A pentacyclic triterpenoid that is 24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid bearing an oxo substituent at position 2, a hydroxy substituent at position 3 and two methyl groups at positions 9 and 13. An antioxidant and anti-inflammatory agent. Potently inhibits lipid peroxidation in mitochondria and inhibits TNF-α-induced NFκB activation. Also shown to inhibit topoisomerase II activity in vitro (IC50 = 7.41 μM).
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C29H38O4
Net Charge 0
Average Mass 450.60960
Monoisotopic Mass 450.27701
InChI InChI=1S/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26-,27+,28-,29+/m1/s1
SMILES [H][C@@]12C[C@@](C)(CC[C@]1(C)CC[C@]1(C)C3=CC=C4C(C)=C(O)C(=O)C=C4[C@]3(C)CC[C@@]21C)C(O)=O
Metabolite of Species Details
Tripterygium wilfordii (NCBI:txid458696) Found in root (BTO:0001188). Root extract See: PubMed
Tripterygium wilfordii (NCBI:txid458696) Found in root (BTO:0001188). Previous component: root bark; See: DOI
Celastrus hypoleucus (NCBI:txid489980) Found in root (BTO:0001188). See: PubMed
Celastrus orbiculatus (NCBI:txid85181) Found in root (BTO:0001188). See: PubMed
Celastrus paniculatus (NCBI:txid994668) Found in root (BTO:0001188). Previous component: root outer bark; See: DOI
Roles Classification
Chemical Role(s): antioxidant
A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
EC [DNA topoisomerase (ATP-hydrolysing)] inhibitor
A topoisomerase inhibitor that inhibits DNA topoisomerase (ATP-hydrolysing), EC (also known as topoisomerase II and as DNA gyrase), which catalyses ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands.
Hsp90 inhibitor
An EC (non-chaperonin molecular chaperone ATPase) inhibitor that blocks the action of heat shock protein 90.
Application(s): anti-inflammatory drug
A substance that reduces or suppresses inflammation.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing celastrol (CHEBI:63959) has role anti-inflammatory drug (CHEBI:35472)
celastrol (CHEBI:63959) has role antineoplastic agent (CHEBI:35610)
celastrol (CHEBI:63959) has role antioxidant (CHEBI:22586)
celastrol (CHEBI:63959) has role EC [DNA topoisomerase (ATP-hydrolysing)] inhibitor (CHEBI:50750)
celastrol (CHEBI:63959) has role Hsp90 inhibitor (CHEBI:63962)
celastrol (CHEBI:63959) has role metabolite (CHEBI:25212)
celastrol (CHEBI:63959) is a monocarboxylic acid (CHEBI:25384)
celastrol (CHEBI:63959) is a pentacyclic triterpenoid (CHEBI:25872)
(2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid
Synonyms Sources
(2R,4aS,6aS,12bR,14aS,14bR)-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-2-picenecarboxylic acid ChEBI
3-hydroxy-9β,13α-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid ChEBI
D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-, (20alpha)- ChemIDplus
Tripterine ChemIDplus
Manual Xrefs Databases
HMDB0002385 HMDB
KR20100097843 Patent
US2011263693 Patent
View more database links
Registry Numbers Types Sources
2194425 Reaxys Registry Number Reaxys
34157-83-0 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
11809076 PubMed citation Europe PMC
15593077 PubMed citation Europe PMC
20934245 PubMed citation Europe PMC
20954803 PubMed citation Europe PMC
21134410 PubMed citation Europe PMC
21414301 PubMed citation Europe PMC
21425580 PubMed citation Europe PMC
21466843 PubMed citation Europe PMC
21569548 PubMed citation Europe PMC
21666907 PubMed citation Europe PMC
21850367 PubMed citation Europe PMC
21865725 PubMed citation Europe PMC
21866552 PubMed citation Europe PMC
22087583 PubMed citation Europe PMC
22206928 PubMed citation Europe PMC
22334592 PubMed citation Europe PMC
Last Modified
10 September 2012